Kayentis

Guillaume Juge, CEO
186 South Street Suite 600
Boston, MA 02111 US
Kayentis

Company Overview

Kayentis, a global expert in electronic data capture for patients in clinical trials, helps sponsors and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Kayentis has been involved in clinical development since 2003. Over the last ten years, it has specialized in electronic Clinical Outcome Assessment (eCOA) solutions for phases II/III in a broad range of therapeutic areas. It has conducted digital data collection for over 260 clinical trials in 79 countries (16,000 sites and 90,000 patients) and employing 120 different languages. The company develops a full range of services and is now enlarging its eCOA solutions portfolio to extend connection with medical devices, as well as to enhance patient engagement. 

Follow us on LinkedIn to discover new content every week!